✦ LIBER ✦

Pharmacokinetic (PK) interaction between epidoxorubicin (EPI) and docetaxel (TXT) in patients with metastatic breast cancer (MBC)

✍ Scribed by Cattel, L.; Airoldi, M.; Brusa, P.; Tagini, V.; Recalenda, V.; Marchionatti, S.; Bumma, C.; Pedani, F.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

382 Preliminary efficacy and tolerance r

✍ A. Chahine; L. Trandafir; H. Errihani; G. Des Guetz; M. Musset; Cl. Jasmin; E. C 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 171 KB

373 Lack of pharmacokinetic interaction

✍ A. Rakhit; S. Fettner; S. Davis; R. Abbas; F. De Rosa; U. Brennschneidt; C. Twel 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 177 KB

670 Phase III comparison of docetaxel (D

✍ P. Ravdin; J. Erban; B. Overmoyer; G.T. Budd; L. Hutchins; E. Lower; L. Laufman; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 141 KB

Phase II study of weekly docetaxel (Taxo

✍ F.J. Esteva; V. Valero; D. Booser; L.T. Guerra; J.L. Murray; L. Pusztai; M. Cris 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 198 KB

In vivo synergism between docetaxel and

✍ Athanasios Alexopoulos; M.V Karamouzis; G Rigatos 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 81 KB

0-73. Pharmacokinetic interaction betwee

✍ M. Dowsett; C.U. Pfister; S.R.D. Johnston; S.J. Houston; D.W. Miles; J.A. Verbee 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 151 KB